Vesper Bio
København, Denmark · $873K raised
- Headquarters
- København
- Website
- vesperbio.com
- Total Funding
- $873K
- Last Round
- $873K GrantJan 2024
- Rounds
- 1
About
Vesper Bio is a clinical-stage biotech company that positions itself as a pioneer in sortilin biology. The company builds on the foundational research of its founders, including Anders Nykjær, who was involved in the discovery of sortilin as a drug target. Vesper Bio's mission is to translate that scientific insight, combined with inspiration from patients, into innovative treatments for people facing devastating or fatal disorders.
Summary
Vesper Bio is a Biotech company based in København, Denmark. It has raised $873K in total across 1 round, most recently a $873K Grant round in Jan 2024. Investors include Michael J. Fox Foundation.
Funding History
Jan 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vesper-bio"><img src="https://indexed.vc/api/badge/company/vesper-bio" alt="Vesper Bio on Indexed.vc" width="260" height="76" /></a>